The era of minimally invasive vitreous surgery: new insights into diabetic retinopathy surgery
10.3760/cma.j.cn511434-20211206-00681
- VernacularTitle:微创玻璃体手术时代：糖尿病视网膜病变手术的新认识
- Author:
Lin LYU
1
;
Shida CHEN
Author Information
1. 中山大学中山眼科中心 眼科学国家重点实验室 广东省眼科视觉科学重点实验室 广东省眼部疾病临床医学研究中心，广州 510060
- Keywords:
Diabetic retinopathy;
Vitrectomy;
Surgical procedures, minimally invasive;
Editorial
- From:
Chinese Journal of Ocular Fundus Diseases
2022;38(1):1-5
- CountryChina
- Language:Chinese
-
Abstract:
Vitrectomy is the preferred surgical method for diabetic retinopathy, especially in the stage of proliferative diabetic retinopathy. Vitrectomy for diabetic retinopathy involves all aspects of vitrectomy, which is one of the signs of maturity of retinal surgeons. With the application of minimally invasive vitrectomy and perioperative anti-neovascularization drugs, indications and timing of surgery, perioperative medication, management of vitreous, and whether combined with cataract surgery have changed greatly, and new understanding is needed. Evidence-based clinical research on the timing of diabetic retinopathy surgery and perioperative drug use should be carried out to provide a new theoretical basis for the surgical treatment of diabetic retinopathy.
